Schedule of Segment Reporting Information |
The segment information is summarized as follows: | | | | | | | | | | | | | | | Business Segment Assets | | September 30, 2022 | | December 31, 2021 | Human Nutrition & Health | | $ | 1,169,395 | | | $ | 727,131 | | Animal Nutrition & Health | | 189,652 | | | 158,971 | | Specialty Products | | 169,817 | | | 184,628 | | Other and Unallocated (1) | | 104,144 | | | 128,595 | | Total | | $ | 1,633,008 | | | $ | 1,199,325 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | Business Segment Net Sales | | Three Months Ended September 30, | | Nine Months Ended September 30, | | | 2022 | | 2021 | | 2022 | | 2021 | Human Nutrition & Health | | $ | 142,655 | | | $ | 111,200 | | | $ | 396,728 | | | $ | 327,187 | | Animal Nutrition & Health | | 65,604 | | | 56,192 | | | 197,546 | | | 161,821 | | Specialty Products | | 29,641 | | | 27,615 | | | 99,622 | | | 89,645 | | Other and Unallocated (2) | | 6,367 | | | 2,862 | | | 15,931 | | | 7,237 | | Total | | $ | 244,267 | | | $ | 197,869 | | | $ | 709,827 | | | $ | 585,890 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | Business Segment Earnings Before Income Taxes | | Three Months Ended September 30, | | Nine Months Ended September 30, | | | 2022 | | 2021 | | 2022 | | 2021 | Human Nutrition & Health | | $ | 20,584 | | | $ | 19,801 | | | $ | 64,592 | | | $ | 58,512 | | Animal Nutrition & Health | | 8,036 | | | 7,442 | | | 26,943 | | | 16,059 | | Specialty Products | | 7,105 | | | 6,455 | | | 24,785 | | | 23,373 | | Other and Unallocated (2) | | (2,100) | | | (1,185) | | | (4,439) | | | (4,263) | | Interest and other expense | | (2,540) | | | (428) | | | (3,908) | | | (1,594) | | Total | | $ | 31,085 | | | $ | 32,085 | | | $ | 107,973 | | | $ | 92,087 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | Depreciation/Amortization | | Three Months Ended September 30, | | Nine Months Ended September 30, | | | 2022 | | 2021 | | 2022 | | 2021 | Human Nutrition & Health | | $ | 9,569 | | | $ | 7,472 | | | $ | 24,316 | | | $ | 22,486 | | Animal Nutrition & Health | | 1,681 | | | 1,932 | | | 5,010 | | | 5,512 | | Specialty Products | | 1,839 | | | 1,997 | | | 5,670 | | | 6,351 | | Other and Unallocated (2) | | 1,008 | | | 758 | | | 2,962 | | | 2,273 | | Total | | $ | 14,097 | | | $ | 12,159 | | | $ | 37,958 | | | $ | 36,622 | |
| | | | | | | | | | | | | | | Capital Expenditures | | Nine Months Ended September 30, | | | 2022 | | 2021 | Human Nutrition & Health | | $ | 22,513 | | | $ | 14,492 | | Animal Nutrition & Health | | 8,748 | | | 4,557 | | Specialty Products | | 3,139 | | | 2,281 | | Other and Unallocated (2) | | 550 | | | 238 | | Total | | $ | 34,950 | | | $ | 21,568 | |
| | | (1) Other and Unallocated assets consist of certain cash, capitalized loan issuance costs, other assets, investments, and income taxes, which the Company does not allocate to its individual business segments. It also includes assets associated with a few minor businesses which individually do not meet the quantitative thresholds for separate presentation. | | (2) Other and Unallocated consists of a few minor businesses which individually do not meet the quantitative thresholds for separate presentation and corporate expenses that have not been allocated to a segment. Unallocated corporate expenses consist of: (i) Transaction and integration costs, ERP implementation costs, and unallocated legal fees totaling $1,640 and $2,816 for the three and nine months ended September 30, 2022, respectively, and $305 and $1,005 for the three and nine months ended September 30, 2021, respectively, and (ii) Unallocated amortization expense of $855 and $2,475 for the three and nine months ended September 30, 2022, respectively, and $675 and $2,024 for the three and nine months ended September 30, 2021, respectively, related to an intangible asset in connection with a company-wide ERP system implementation and capitalized loan issuance costs that were included in interest expense in the Company's condensed consolidated statements of earnings. |
|